FDA Hears Testimony on Prescription Drug User Fee Act

by Madjackfrost on April 13, 2010

MedPage Today — ROCKVILLE, Md. — The FDA on Monday launched the start of a two-year process to reauthorize the landmark Prescription Drug User Fee Act (PDUFA) program, which charges drug companies fees to fund the agency’s research into drug safety and efficacy.

Join hundreds of students and get all book resources for FREE! Subscribe to Pharmacy E-books via RSS or via E-mail

Leave a Comment

*